-
PD for Wed 05 Nov 2025
Wednesday | Nov 5 2025Guild president lands top international role, palliative care issues brought to Canberra, study reinforces COVID vax heart benefit, and more
-
PD breaking news – Professor Trent Twomey elected head of World Pharmacy Council
Tuesday | Nov 4 2025Pharmacy Guild of Australia National President to take up WPC presidency. The World Pharmacy Council (WPC)…
-
Bendigo UFS rewards community
Tuesday | Nov 4 2025BENDIGO UFS Pharmacies has launched a new membership program designed to deliver more value to customers while strengthening its long-standing commitment to the local community.
-
Opioid best practice disconnect
Tuesday | Nov 4 2025RESEARCHERS from South Australia looking into opioid prescribing in rural general practice report a marked disparity between evidencebased guidelines for chronic pain management and the reality of rural medical practice.
-
Nicotine dependence rising in US teen vapers
Tuesday | Nov 4 2025US RESEARCH has revealed that while there have been recent decreases in nicotine vaping prevalence among younger people, those who continue to vape are becoming more nicotine-dependent and are less able to successfully quit.
-
Retinoid action
Tuesday | Nov 4 2025DIFFERIN Acne Treatment contains the potent retinoid Adapalene to treat and prevent acne and restore the skin’s natural texture and tone.
-
Back the bid
Tuesday | Nov 4 2025GLUCOJEL has teamed up with Netball Australia in its bid for the game’s inclusion at the Brisbane 2032 Olympics.
-
Innovation event for owners
Tuesday | Nov 4 2025THE Pharmacy Innovation Assembly will take place in Melbourne on 08 Nov, offering pharmacy owners insights and actionable strategies around running a business.
-
Iqirvo PBS listed for liver disease
Tuesday | Nov 4 2025IQIRVO (elafibranor, Ipsen) is now available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
-
ACPHARM fined
Tuesday | Nov 4 2025ACPHARM in Queensland has been issued with infringement notices from the Therapeutic Goods Administration (TGA) for the alleged unlawful advertising of medicinal cannabis.
PARTNER SITES
to top